| Symbol | ACAD |
|---|---|
| Name | ACADIA PHARMACEUTICALS INC |
| Sector | HEALTH CARE |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 12830 EL CAMINO REAL, SAN DIEGO, CA 92130 |
| Telephone | 858-558-2871 |
| Fax | — |
| — | |
| Website | https://www.acadia.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinsons, Alzheimers, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The companys patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology. Additional info from NASDAQ: |
Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology (AAN) Annual Meeting
Read moreAcadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026
Read moreSchneyer Mark C. 🟡 adjusted position in 2.7K shares (1 derivative) of ACADIA PHARMACEUTICALS INC (ACAD) at $22.20 Transaction Date: Apr 05, 2026 | Filing ID: 000005
Read moreKihara James 🟡 adjusted position in 1.0K shares (1 derivative) of ACADIA PHARMACEUTICALS INC (ACAD) at $22.20 Transaction Date: Apr 05, 2026 | Filing ID: 000005
Read moreAcadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome
Read moreOwen Adams Catherine 🟡 adjusted position in 11.6K shares (1 derivative) of ACADIA PHARMACEUTICALS INC (ACAD) at $21.47 Transaction Date: Mar 24, 2026 | Filing ID: 000003
Read moreRhodes Jennifer J 🟡 adjusted position in 3.8K shares (1 derivative) of ACADIA PHARMACEUTICALS INC (ACAD) at $21.47 Transaction Date: Mar 24, 2026 | Filing ID: 000005
Read moreThompson Elizabeth H.Z. 🟡 adjusted position in 3.4K shares (1 derivative) of ACADIA PHARMACEUTICALS INC (ACAD) at $21.47 Transaction Date: Mar 24, 2026 | Filing ID: 000003
Read moreKihara James 🟡 adjusted position in 1.9K shares (2 derivative) of ACADIA PHARMACEUTICALS INC (ACAD) at $21.73 Transaction Date: Mar 24, 2026 | Filing ID: 000003
Read moreSchneyer Mark C. 🟡 adjusted position in 7.4K shares (2 derivative) of ACADIA PHARMACEUTICALS INC (ACAD) at $21.72 Transaction Date: Mar 24, 2026 | Filing ID: 000003
Read more